These results suggest that Wnt2b/β-catenin signalling mediates HCC-TAMs-induced HCC EMT, and silencing the expression of Wnt2b or CTNNB1 can reverse the tumour-promoting role of TAMs. The gene discussed is WNT2B; the disease is hepatocellular carcinoma.